B-Act, our single strain Bacillus licheniformis probiotic was put to the test to evaluate its ability to improve health and growth performance parameters under a necrotic enteritis (NE) challenge. The results showed that the B-Act treatment group performed as well as the group that received the antibiotic treatment.
The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.
To view all products and services, select Global from the dropdown menu or click .
Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.
Update your browser to view this website correctly. Update my browser now